{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:49:39Z","timestamp":1788263379947,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003509","name":"\u00d6rebro Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014148","name":"Centro Hospitalar Universit\u00e1rio do Porto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115565"],"award-info":[{"award-number":["115565"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-974449"],"award-info":[{"award-number":["SLS-974449"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005624","name":"Medizinischen Hochschule Hannover","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031015","name":"Hospital Cl\u00ednic de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["FAI-2023-1006"],"award-info":[{"award-number":["FAI-2023-1006"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2024- 49"],"award-info":[{"award-number":["2024- 49"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Foundation King Gustaf V 80-\u00e5rsfond","doi-asserted-by":"publisher","award":["FAI-2023-1055"],"award-info":[{"award-number":["FAI-2023-1055"]}],"id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-995557"],"award-info":[{"award-number":["R-995557"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-939667"],"award-info":[{"award-number":["R-939667"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-995882"],"award-info":[{"award-number":["R-995882"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015763","name":"Szegedi Tudom\u00e1nyegyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009800","name":"Professor Nanna Svartz Foundation Fund","doi-asserted-by":"publisher","award":["2021-00436"],"award-info":[{"award-number":["2021-00436"]}],"id":[{"id":"10.13039\/501100009800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018780","name":"Servicio Andaluz de Salud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009806","name":"Ulla and Gustaf af Ugglas Foundation","doi-asserted-by":"publisher","award":["2023-025029"],"award-info":[{"award-number":["2023-025029"]}],"id":[{"id":"10.13039\/501100009806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["671_2018"],"award-info":[{"award-number":["671_2018"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007370","name":"Universit\u00e9 Catholique de Louvain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003077","name":"Knowledge Foundation","doi-asserted-by":"publisher","award":["20200017"],"award-info":[{"award-number":["20200017"]}],"id":[{"id":"10.13039\/100003077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006388","name":"H\u00f4pitaux Universitaires de Gen\u00e8ve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023670","name":"The Key Find","doi-asserted-by":"publisher","award":["OLL-1000881"],"award-info":[{"award-number":["OLL-1000881"]}],"id":[{"id":"10.13039\/501100023670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ard.2025.04.003","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T15:36:23Z","timestamp":1747236983000},"page":"1180-1194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity\u2013could anti-LIN28A enhance precision in diagnostics?"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-5395","authenticated-orcid":false,"given":"Ioannis","family":"Parodis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-6629","authenticated-orcid":false,"given":"Denis","family":"Lagutkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-9471","authenticated-orcid":false,"given":"Julius","family":"Lindblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-4729","authenticated-orcid":false,"given":"Helena","family":"Idborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Orietta","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5992-2470","authenticated-orcid":false,"given":"Janique M.","family":"Peyper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Barturen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Johan","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7632-4154","authenticated-orcid":false,"given":"Marta E.","family":"Alarc\u00f3n-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-172X","authenticated-orcid":false,"given":"Natalia","family":"Sherina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9894-6966","authenticated-orcid":false,"given":"Dionysis","family":"Nikolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ard.2025.04.003_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/BOR.0000000000000922","article-title":"An update on autoantibodies in systemic lupus erythematosus","volume":"35","author":"G\u00f3mez-Ba\u00f1uelos","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ard.2025.04.003_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ard.2025.04.003_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103025","article-title":"Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus","volume":"136","author":"Lindblom","year":"2023","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.ard.2025.04.003_bib0004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ard.2025.04.003_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.02.009","article-title":"Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus","volume":"91","author":"Lewis","year":"2018","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.ard.2025.04.003_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-021-00710-2","article-title":"Differentiating between UCTD and early-stage SLE: from definitions to clinical approach","volume":"18","author":"Sciascia","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2025.04.003_bib0007","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.04.003_bib0008","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nrrheum.2013.103","article-title":"Diagnostic criteria for systemic lupus erythematosus: has the time come?","volume":"9","author":"Bertsias","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.04.003_bib0009","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/annrheumdis-2019-216155","article-title":"In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR\/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment","volume":"79","author":"Adamichou","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"16","key":"10.1016\/j.ard.2025.04.003_bib0010","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ard.2025.04.003_bib0011","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/acr2.11343","article-title":"Four systemic lupus erythematosus subgroups, defined by autoantibodies status, differ regarding HLA-DRB1 genotype associations and immunological and clinical manifestations","volume":"4","author":"Diaz-Gallo","year":"2022","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.003_bib0012","first-page":"74","article-title":"From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study","volume":"41","author":"Kapsala","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.003_bib0013","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1038\/s41598-023-32428-4","article-title":"Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity","volume":"13","author":"Cunningham","year":"2023","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ard.2025.04.003_bib0014","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/ene.14290","article-title":"Identification of novel candidate autoantibodies in Alzheimer\u2019s disease","volume":"27","author":"Wang","year":"2020","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.ard.2025.04.003_bib0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41416-021-01572-x","article-title":"A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications","volume":"126","author":"Patel","year":"2022","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ard.2025.04.003_bib0016","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ard.2025.04.003_bib0017","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ard.2025.04.003_bib0018","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.04.003_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1257085","article-title":"PRECISESADS Clinical Consortium; Alarc\u00f3n-Riquelme ME, Parodis I. Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus","volume":"14","author":"Lindblom","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.003_bib0020","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/ar3250","article-title":"Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus","volume":"13","author":"Biesen","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.ard.2025.04.003_bib0021","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.ard.2025.04.003_bib0022","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ard.2025.04.003_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953726","article-title":"Autoantibodies\u2014enemies, and\/or potential allies?","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ard.2025.04.003_bib0024","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/cancers13040813","article-title":"Anti-cancer auto-antibodies: roles, applications and open issues","volume":"13","author":"de Jonge","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"14","key":"10.1016\/j.ard.2025.04.003_bib0025","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1177\/0961203320959696","article-title":"Detection of putative autoantibodies in systemic lupus erythematous using a novel native-conformation protein microarray platform","volume":"29","author":"Mak","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.ard.2025.04.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/516593","article-title":"Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosis","volume":"2014","author":"Maslyanskiy","year":"2014","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.ard.2025.04.003_bib0027","first-page":"1260","article-title":"Clinical utility and serological connections of anti-RA33 antibodies in systemic lupus erythematosus","volume":"21","author":"Isenberg","year":"1994","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.ard.2025.04.003_bib0028","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/anr.1780321204","article-title":"Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis","volume":"32","author":"Hassfeld","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ard.2025.04.003_bib0029","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1136\/annrheumdis-2015-208529","article-title":"Antibodies to native and citrullinated RA33 (hnRNP A2\/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis","volume":"75","author":"Konig","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.04.003_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI119504","volume":"100","author":"Skriner","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ard.2025.04.003_bib0031","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.003_bib0032","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/cei\/uxac030","article-title":"Antibodies as biomarkers for cancer risk: a systematic review","volume":"209","author":"Monroy-Iglesias","year":"2022","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.ard.2025.04.003_bib0033","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"16","key":"10.1016\/j.ard.2025.04.003_bib0034","doi-asserted-by":"crossref","first-page":"9432","DOI":"10.3390\/ijms23169432","article-title":"IgA antiphospholipid antibodies in antiphospholipid syndrome and systemic lupus erythematosus","volume":"23","author":"Reshetnyak","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ard.2025.04.003_bib0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbacli.2016.05.004","article-title":"Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"6","author":"Shimanovsky","year":"2016","journal-title":"BBA Clin"},{"issue":"754","key":"10.1016\/j.ard.2025.04.003_bib0036","doi-asserted-by":"crossref","first-page":"eadl3848","DOI":"10.1126\/scitranslmed.adl3848","article-title":"Lupus IgA1 autoantibodies synergize with IgG to enhance plasmacytoid dendritic cell responses to RNA-containing immune complexes","volume":"16","author":"Waterman","year":"2024","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.ard.2025.04.003_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071458","article-title":"Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease","volume":"8","author":"Villalta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ard.2025.04.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109107","article-title":"Fecal immunoglobulin A (IgA) and its subclasses in systemic lupus erythematosus patients are nuclear antigen reactive and this feature correlates with gut permeability marker levels","volume":"242","author":"Gudi","year":"2022","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.003_bib0039","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"7776","key":"10.1016\/j.ard.2025.04.003_bib0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-019-1595-3","article-title":"Analysis of the B cell receptor repertoire in six immune-mediated diseases","volume":"574","author":"Bashford-Rogers","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ard.2025.04.003_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2021.194684","article-title":"Sj\u00f6gren syndrome antigen B regulates LIN28-let-7 axis in Caenorhabditis elegans and human","volume":"1864","author":"Kim","year":"2021","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.ard.2025.04.003_bib0042","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.2147\/JIR.S312963","article-title":"Overexpression of Lin28a aggravates psoriasis-like phenotype by regulating the proliferation and differentiation of keratinocytes","volume":"14","author":"Jang","year":"2021","journal-title":"J Inflamm Res"},{"issue":"10","key":"10.1016\/j.ard.2025.04.003_bib0043","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.7150\/ijbs.97434","article-title":"Nephron-specific Lin28A overexpression triggers severe inflammatory response and kidney damage","volume":"20","author":"Futorian","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"6","key":"10.1016\/j.ard.2025.04.003_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121256","article-title":"Let-7 miRNAs modulate the activation of NF-\u03baB by targeting TNFAIP3 and are involved in the pathogenesis of lupus nephritis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"issue":"34","key":"10.1016\/j.ard.2025.04.003_bib0045","doi-asserted-by":"crossref","first-page":"eabn3106","DOI":"10.1126\/sciadv.abn3106","article-title":"Lin28a induces SOX9 and chondrocyte reprogramming via HMGA2 and blunts cartilage loss in mice","volume":"8","author":"Jouan","year":"2022","journal-title":"Sci Adv"},{"issue":"17","key":"10.1016\/j.ard.2025.04.003_bib0046","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1111\/jcmm.15506","article-title":"Lin28a up-regulation is associated with the formation of restenosis via promoting proliferation and migration of vascular smooth muscle cells","volume":"24","author":"Zou","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"14","key":"10.1016\/j.ard.2025.04.003_bib0047","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1242\/dev.117580","article-title":"LIN28: roles and regulation in development and beyond","volume":"142","author":"Tsialikas","year":"2015","journal-title":"Development"},{"issue":"10","key":"10.1016\/j.ard.2025.04.003_bib0048","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3390\/ijms19102852","article-title":"Neglected functions of TFCP2\/TFCP2L1\/UBP1 transcription factors may offer valuable insights into their mechanisms of action","volume":"19","author":"Taracha","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ard.2025.04.003_bib0049","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/tpj.2010.77","article-title":"Network analysis of transcriptional regulation in response to intramuscular interferon-\u03b2-1a multiple sclerosis treatment","volume":"12","author":"Hecker","year":"2012","journal-title":"Pharmacogenomics J"},{"issue":"12","key":"10.1016\/j.ard.2025.04.003_bib0050","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.37708","article-title":"Identification of a susceptibility locus in STAT4 for Beh\u00e7et\u2019s disease in Han Chinese in a genome-wide association study","volume":"64","author":"Hou","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ard.2025.04.003_bib0051","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.sjbs.2021.04.076","article-title":"Identification of differentially expressed genes and pathways crosstalk analysis in rheumatoid and osteoarthritis using next-generation sequencing and protein-protein networks","volume":"28","author":"Qiu","year":"2021","journal-title":"Saudi J Biol Sci"},{"issue":"6","key":"10.1016\/j.ard.2025.04.003_bib0052","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.4049\/jimmunol.168.6.2847","article-title":"The ubiquitously expressed DNA-binding protein late SV40 factor binds Ig switch regions and represses class switching to IgA","volume":"168","author":"Drouin","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.ard.2025.04.003_bib0053","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard-2022-223808","article-title":"Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes","volume":"82","author":"Choi","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ard.2025.04.003_bib0054","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/rheumatology\/kes261","article-title":"Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese","volume":"52","author":"Li","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.ard.2025.04.003_bib0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.autrev.2008.06.005","article-title":"Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value","volume":"7","author":"G\u00f3mez-Puerta","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.ard.2025.04.003_bib0056","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrm3884","article-title":"The structure, function and evolution of proteins that bind DNA and RNA","volume":"15","author":"Hudson","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"43","key":"10.1016\/j.ard.2025.04.003_bib0057","doi-asserted-by":"crossref","first-page":"eabo5840","DOI":"10.1126\/sciadv.abo5840","article-title":"ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus","volume":"8","author":"Manolakou","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.ard.2025.04.003_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2025.04.008","article-title":"Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1","author":"Lindblom","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ard.2025.04.003_bib0058","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1073\/pnas.82.11.3814","article-title":"Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein","volume":"82","author":"Hahn","year":"1985","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:04:49Z","timestamp":1778040289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725008891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0003496725008891"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.04.003","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity\u2013could anti-LIN28A enhance precision in diagnostics?","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}